CLOS
BIIB icon

Compagnie Lombard Odier SCmA’s Biogen BIIB Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$2.7K – 446
2025
Q2 		$2.51K Hold
20
– – ﹤0.01% 411
2025
Q1 		$2.74K Sell
20
-400
-95% -$57.2K ﹤0.01% 449
2024
Q4 		$64.2K Hold
420
– – ﹤0.01% 318
2024
Q3 		$81.4K Buy
420
+20
+5% +$4.18K ﹤0.01% 305
2024
Q2 		$92.7K Hold
400
– – ﹤0.01% 292
2024
Q1 		$86.3K Hold
400
– – ﹤0.01% 317
2023
Q4 		$104K Hold
400
– – ﹤0.01% 349
2023
Q3 		$103K Buy
400
+215
+116% +$57.5K ﹤0.01% 351
2023
Q2 		$52.7K Sell
185
-200
-52% -$59.5K ﹤0.01% 411
2023
Q1 		$107K Sell
385
-512
-57% -$142K ﹤0.01% 367
2022
Q4 		$248K Buy
897
+512
+133% +$145K 0.01% 267
2022
Q3 		$103K Buy
385
+185
+93% +$39.3K ﹤0.01% 383
2022
Q2 		$40K Hold
200
– – ﹤0.01% 467
2022
Q1 		$42K Buy
+200
New +$43.5K ﹤0.01% 470
2021
Q3 		– Sell
-100
Closed -$35K – 644
2021
Q2 		$35K Sell
100
-50
-33% -$15.1K ﹤0.01% 519
2021
Q1 		$42K Sell
150
-150
-50% -$40.5K ﹤0.01% 526
2020
Q4 		$73K Hold
300
– – ﹤0.01% 404
2020
Q3 		$85K Hold
300
– – ﹤0.01% 350
2020
Q2 		$81K Buy
300
+200
+200% +$60.1K ﹤0.01% 340
2020
Q1 		$32K Hold
100
– – ﹤0.01% 375
2019
Q4 		$30K Sell
100
-307
-75% -$85.2K ﹤0.01% 396
2019
Q3 		$94K Hold
407
– – ﹤0.01% 311
2019
Q2 		$95K Sell
407
-1,886
-82% -$435K ﹤0.01% 308
2019
Q1 		$542K Sell
2,293
-1,100
-32% -$346K 0.02% 187
2018
Q4 		$1.02M Buy
3,393
+15
+0.4% +$4.79K 0.04% 154
2018
Q3 		$1.19M Buy
3,378
+2,025
+150% +$697K 0.04% 157
2018
Q2 		$393K Buy
1,353
+150
+12% +$42.2K 0.01% 233
2018
Q1 		$329K Sell
1,203
-1,273
-51% -$395K 0.01% 260
2017
Q4 		$788K Buy
2,476
+738
+42% +$237K 0.01% 255
2017
Q3 		$544K Sell
1,738
-1,202
-41% -$356K 0.02% 255
2017
Q2 		$796K Sell
2,940
-440
-13% -$116K 0.03% 235
2017
Q1 		$926K Buy
3,380
+1,246
+58% +$352K 0.03% 226
2016
Q4 		$605K Sell
2,134
-1,100
-34% -$326K 0.02% 303
2016
Q3 		$1.01M Sell
3,234
-3,015
-48% -$893K 0.03% 267
2016
Q2 		$1.51M Sell
6,249
-5,512
-47% -$1.45M 0.04% 224
2016
Q1 		$3.06M Sell
11,761
-1,079
-8% -$285K 0.09% 134
2015
Q4 		$3.93M Buy
12,840
+6,351
+98% +$1.82M 0.12% 103
2015
Q3 		$1.89M Buy
6,489
+4,942
+319% +$1.63M 0.08% 153
2015
Q2 		$625K Sell
1,547
-385
-20% -$155K 0.02% 274
2015
Q1 		$816K Sell
1,932
-797
-29% -$314K 0.03% 250
2014
Q4 		$926K Buy
2,729
+220
+9% +$71.2K 0.04% 206
2014
Q3 		$830K Buy
2,509
+392
+19% +$129K 0.03% 217
2014
Q2 		$668K Hold
2,117
– – 0.03% 263
2014
Q1 		$648K Sell
2,117
-154
-7% -$48.9K 0.03% 276
2013
Q4 		$636K Buy
+2,271
New +$587K 0.03% 273

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Compagnie Lombard Odier SCmA's BIIB Position: Q3 2025 in Review

Compagnie Lombard Odier SCmA sold out of Biogen (BIIB) in Q3 2025, closing a stake of 20 shares — an estimated $2.7K sold.

Compagnie Lombard Odier SCmA first reported a position in BIIB in Q4 2013 and held it in 45 quarters. The position peaked at $3.93M in Q4 2015. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Compagnie Lombard Odier SCmA reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 20 Biogen shares in Q3 2025, an estimated $2.7K.
  • Compagnie Lombard Odier SCmA first reported a position in Biogen in Q4 2013 and held it in 45 quarters.
  • Compagnie Lombard Odier SCmA's Biogen position peaked at $3.93M in Q4 2015.
  • 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2025, filed 6 Nov 2025.